Osteoarthritis Trial, Recruiting NCT06228573 Sponsor: McMaster University Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT06228573
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who live independently in the community in Sherbrooke (Quebec) or Hamilton or London (Ontario)
  • People aged 45 or older
  • People who have been diagnosed with knee osteoarthritis, OR who have knee pain that occurs with movement, with either no morning knee stiffness or morning stiffness that lasts 30 minutes or less
  • People who have experienced average knee pain of at least 3 out of 10 over the past month

Who may not be able to join:

  • People who have an inflammatory arthritis condition that affects the whole body (such as rheumatoid arthritis)
  • People who have had any injection into the knee in the past 3 months
  • People who are unable to get up and down from the floor on their own
  • People who have had surgery or a significant injury to a leg or foot in the past 6 months
  • People who are currently taking part in another clinical trial for osteoarthritis
  • People who use a walking aid such as a cane, walker, or crutches
  • People who are currently receiving treatment for their knee osteoarthritis pain, such as physiotherapy
  • People who have planned trips or absences lasting more than one week during the trial period
  • People who have neurological or psychiatric conditions that would make a type of gentle brain stimulation called transcranial direct current stimulation (tDCS) unsafe for them (confirm with trial site)
  • People who have had brain surgery or have a history of a brain tumour
  • People who have any metal implants in their body
  • People who have epilepsy or a history of substance misuse or dependence
  • People who have a cochlear implant (hearing device) or an ocular implant (eye device)
  • People who have a pacemaker or implanted cardiac defibrillator (heart devices)
  • People who have eczema on their scalp

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lisa Carlesso, PhD, McMaster University

Phone: 2896805640

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
McMaster University
Registry
ClinicalTrials.gov
Start date
20 October 2024
Est. completion
15 September 2025

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Percentage of complete follow up

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov